Background Since December, 2019, Wuhan, China, has experienced an outbreak of
coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome …

Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …

Background Neuraminidase inhibitors were widely used during the 2009–10 influenza A H1N1
pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a …

Importance COVID-19 is associated with clinically significant symptoms despite resolution
of the acute infection (ie, post-COVID-19 syndrome). Fatigue and cognitive impairment are …

Zinc oxide (ZnO), with its excellent luminescent properties and the ease of growth of its
nanostructures, holds promise for the development of photonic devices. The recent advances in …

Background No therapeutics have yet been proven effective for the treatment of severe
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …

Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel
betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, …

Background The long-term health consequences of COVID-19 remain largely unclear. The
aim of this study was to describe the long-term health consequences of patients with COVID-…

… Viral particles were negative stained with 1% solution of phosphotungstic acid and observed
by using electron microscopy analysis (B, scale bar 200 nm). Immunofluorescent assays …

The neuro-anatomical substrates of major depressive disorder (MDD) are still not well
understood, despite many neuroimaging studies over the past few decades. Here we present the …